Skip to main content

Phase III randomized trial of amifostine as a radioprotector in head and neck cancer.

Publication ,  Journal Article
Vikram, B
Published in: J Clin Oncol
February 15, 2001

Duke Scholars

Published In

J Clin Oncol

DOI

ISSN

0732-183X

Publication Date

February 15, 2001

Volume

19

Issue

4

Start / End Page

1233 / 1234

Location

United States

Related Subject Headings

  • Xerostomia
  • Randomized Controlled Trials as Topic
  • Radiation-Protective Agents
  • Oncology & Carcinogenesis
  • Humans
  • Head and Neck Neoplasms
  • Amifostine
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Vikram, B. (2001). Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J Clin Oncol, 19(4), 1233–1234. https://doi.org/10.1200/JCO.2001.19.4.1233
Vikram, B. “Phase III randomized trial of amifostine as a radioprotector in head and neck cancer.J Clin Oncol 19, no. 4 (February 15, 2001): 1233–34. https://doi.org/10.1200/JCO.2001.19.4.1233.
Vikram, B. “Phase III randomized trial of amifostine as a radioprotector in head and neck cancer.J Clin Oncol, vol. 19, no. 4, Feb. 2001, pp. 1233–34. Pubmed, doi:10.1200/JCO.2001.19.4.1233.

Published In

J Clin Oncol

DOI

ISSN

0732-183X

Publication Date

February 15, 2001

Volume

19

Issue

4

Start / End Page

1233 / 1234

Location

United States

Related Subject Headings

  • Xerostomia
  • Randomized Controlled Trials as Topic
  • Radiation-Protective Agents
  • Oncology & Carcinogenesis
  • Humans
  • Head and Neck Neoplasms
  • Amifostine
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences